|
FOXM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0933000060831E-09 |
| Normal-vs-Stage2 |
9.839500E-03 |
| Normal-vs-Stage3 |
4.85299999997135E-06 |
| Normal-vs-Stage4 |
2.036200E-03 |
| Stage1-vs-Stage2 |
5.850400E-01 |
| Stage1-vs-Stage3 |
8.437700E-04 |
| Stage1-vs-Stage4 |
1.618420E-03 |
| Stage2-vs-Stage3 |
6.918700E-03 |
| Stage2-vs-Stage4 |
4.613600E-02 |
| Stage3-vs-Stage4 |
6.275600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05391259555654E-14 |
| Normal-vs-AfricanAmerican |
1.92080000016581E-07 |
| Normal-vs-Asian |
1.731810E-02 |
| Caucasian-vs-AfricanAmerican |
4.847000E-01 |
| Caucasian-vs-Asian |
6.258800E-01 |
| AfricanAmerican-vs-Asian |
3.331200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.10862446895044E-15 |
| Normal-vs-Female |
5.60930000226278E-08 |
| Male-vs-Female |
2.438100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55386999999285E-05 |
| Normal-vs-Extreme_Weight |
4.32090000002106E-07 |
| Normal-vs-Obese |
1.97959999947983E-07 |
| Normal-vs-Extreme_Obese |
3.118200E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.441200E-01 |
| Normal_Weight-vs-Obese |
3.193200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.601200E-03 |
| Extreme_Weight-vs-Obese |
4.945700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.284100E-03 |
| Obese-vs-Extreme_Obese |
1.205850E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.159500E-04 |
| Normal-vs-Age(41-60Yrs) |
7.21478432552658E-12 |
| Normal-vs-Age(61-80Yrs) |
1.06640000052671E-07 |
| Normal-vs-Age(81-100Yrs) |
2.653600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.088250E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.318600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.208400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.465570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.667400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.338000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71660019532283E-10 |
| Normal-VS-Type2 PRCC |
9.71060000187762E-08 |
| Normal-VS-KIRP CIMP |
1.495970E-03 |
| Normal-VS-Unclassified PRCC |
2.800200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.986300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.422200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.093650E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.143940E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.315800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.207200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.71480000053104E-07 |
| Normal-vs-N1 |
3.51170000000289E-05 |
| Normal-vs-N2 |
9.866200E-02 |
| N0-vs-N1 |
1.178100E-03 |
| N0-vs-N2 |
1.687560E-01 |
| N1-vs-N2 |
7.445200E-01 |
|
|
